Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer.

Saved in:
Bibliographic Details
Title: Radiotherapy quality assurance in the PROTECT trial - a European randomised phase III-trial comparing proton and photon therapy in the treatment of patients with oesophageal cancer.
Authors: Skinnerup Byskov C; Department of Oncology, Aarhus University Hospital, Denmark. cambys@rm.dk., Mortensen HR; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark., Biston MC; Centre Léon Bérard, Lyon, France., Broggi S; San Raffaele Hospital, Milan, Italy., Bütof R; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany., Canters R; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands., Crehange G; Curie Institute, Paris, France., Defraene G; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium., Doyen J; Centre Antoine Lacassagne, Nice, France., Ehmsen ML; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark., Fabiano S; University Hospital Zurich, Zurich, Switzerland., Fracchiola F; Department of medical physics, APSS, Trento, Italy., Goudjil F; Curie Institute, Paris, France., Haustermans K; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium., Jensen SE; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark., Jensen MF; Danish Centre for Particle Therapy, Aarhus University Hospital, Denmark., Lecornu M; Centre François Baclesse, Caen, France., Makocki S; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany; OncoRay - National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany., Mana AL; Centre Antoine Lacassagne, Nice, France., Martignano A; Department of medical physics, APSS, Trento, Italy., Meijers A; Paul Scherrer Institute, Villigen, Switzerland., Mirandola A; National Centre of Oncology Adrotherapy, Pavia, Italy., Mitrea DA; Centre Antoine Lacassagne, Nice, France., Muijs CT; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, The Netherlands., Møller DS; Department of Oncology, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark., Nordsmark M; Department of Oncology, Aarhus University Hospital, Denmark., Orlandi E; Department of Clinical, Surgical, Diagnostic, and Pediatric Sciences, University of Pavia, Pavia, Italy; Clinical Department, National Center for Oncological Hadrontherapy (Fondazione CNAO), Pavia, Italy., Balermpas P; 1University Hospital Zurich, Zurich, Switzerland., Populaire P; KU Leuven - University of Leuven - Department of Oncology - Laboratory of Experimental Radiotherapy, Belgium; University Hospitals Leuven, Department of Radiation Oncology, Belgium., Scartoni D; Department of Proton Therapy, APSS, Trento., Serrand J; Centre Léon Bérard, Lyon, France., Shamshad M; EBG MedAustron GmbH, Austria., Slim N; San Raffaele Hospital, Milan, Italy., Vanoni V; Department of Radiation Oncology, APSS, Trento, Italy., Vela A; Centre François Baclesse, Caen, France., Vidal M; Centre Antoine Lacassagne, Nice, France., Vilches-Freixas G; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, The Netherlands., Weber D; Paul Scherrer Institute, Villigen, Switzerland., Hoffmann L; Department of Oncology, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, Aarhus University, Denmark.
Source: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2025 Mar 13; Vol. 64, pp. 406-414. Date of Electronic Publication: 2025 Mar 13.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Comparative Study; Multicenter Study
Journal Info: Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 8709065 Publication Model: Electronic Cited Medium: Internet ISSN: 1651-226X (Electronic) Linking ISSN: 0284186X NLM ISO Abbreviation: Acta Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1651-226X
DOI:10.2340/1651-226X.2025.42774